湖南五洲通药业股份有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
130
NMPA:130
Drug Approvals
Aminobutyric Acid Injection
- Product Name
- 氨酪酸注射液
- Approval Number
- 国药准字H20055449
- Approval Date
- Feb 6, 2024
NMPA
Sterile Water For Injection
- Product Name
- 灭菌注射用水
- Approval Number
- 国药准字H43021688
- Approval Date
- Feb 6, 2024
NMPA
Netilmicin Sulfate Injection
- Product Name
- 硫酸奈替米星注射液
- Approval Number
- 国药准字H20056205
- Approval Date
- Feb 6, 2024
NMPA
Sisomicin Sulfate Injection
- Product Name
- 硫酸西索米星注射液
- Approval Number
- 国药准字H20053810
- Approval Date
- Feb 6, 2024
NMPA
Netilmicin Sulfate Injection
- Product Name
- 硫酸奈替米星注射液
- Approval Number
- 国药准字H20056206
- Approval Date
- Feb 6, 2024
NMPA
Sisomicin Sulfate Injection
- Product Name
- 硫酸西索米星注射液
- Approval Number
- 国药准字H20053809
- Approval Date
- Feb 6, 2024
NMPA
Lincomycin Hydrochloride Injection
- Product Name
- 盐酸林可霉素注射液
- Approval Number
- 国药准字H43020912
- Approval Date
- Feb 6, 2024
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 13
- Next
Clinical Trials
No trials found
News
No news found